SunBio,Inc. (KOSDAQ:067370)

Market Cap	84.84B
Revenue (ttm)	2.17B
Net Income (ttm)	1.39B
Shares Out	12.31M
EPS (ttm)	249.33
PE Ratio	27.63
Forward PE	n/a
Dividend	75.00 (1.09%)
Ex-Dividend Date	n/a

Volume	8,436
Average Volume	10,424
Open	6,880.00
Previous Close	6,880.00
Day's Range	6,720.00 - 6,900.00
52-Week Range	5,580.00 - 10,170.00
Beta	0.84
RSI	47.69
Earnings Date	n/a

About SunBio,Inc.

SunBio,Inc., a biotech company, develops, produces, and sells biosimilar and biopharmaceutical products, and medical devices based on its technologies of pegylation worldwide. Its biosimilar products include PEG-filgrastim; and PEG-EPO and uricase which is in preclinical stage. The company offers MucoPEG, a medical device for treatment of dry mouth syndrome; and SynoGEL, a viscosupplement for arthritic Knee. Its preclinical stage biopharmaceuticals candidates target brain stroke and chronic anemia. It also manufactures and sells PEG derivatives...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1997
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 067370